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EDITORIAL POLICIES
SCOPE OF THE JOURNAL
The Journal of Vascular Surgery® is dedicated to
the science and art of vascular surgery and aims to
improve the management of patients with vascular
diseases by publishing relevant papers that report
important medical advances, test new hypotheses,
and address current controversies. To achieve this
goal, the Journal will publish original clinical and
laboratory studies and reports and papers that com-
ment on the social, economic, ethical, legal, and
political factors that relate to these aims.
PEER REVIEW
Principles of peer review
Objectives. The purpose of peer review is to help
ensure that the published papers are of the highest
quality by (1) advising the Editors on the originality
of the work, its importance relative to what has al-
ready been published in the current literature, its
relevance to the objectives of the Journal, its scientific
creditability, and its acceptability for publication,
given the space that is available; and (2) by suggesting
changes and providing advice and assistance to the
authors on important aspects that may improve the
manuscript.
Fairness. The success of peer review requires that
all reviewers exercise careful scientific judgment, be
impartial and equitable, and form a balanced view of
the content of each manuscript. There is no formula
that can guide the reviewers in this task, apart from
the requirement to be objective and fair.
Confidentiality. All documents and information
provided for the purpose of peer review must be kept
entirely confidential. To prevent unauthorized ac-
cess, manuscripts must be stored in a secure manner.
The manuscript must not be shared with other col-
leagues. If a reviewer wishes to seek a colleague’s
opinion on the scientific merit of a manuscript, the
Editors must be consulted first, and the colleague
must adhere to the same standards of confidentiality.
The manuscript must not be photocopied or
shared electronically. When the review is completed,
any personal electronic files should be deleted, and
any printed documents must be destroyed.
Any inquiries received by individual reviewers
about a manuscript should be referred to the Editors.
Competition of interest. The decisions of the
Editors must be fair and objective and they must be
seen to be impartial. Because the final decision on
publication rests with the Editors, their decisions
must not be influenced by The Society for Vascular
Surgery®, the affiliated vascular societies, or represen-
tatives of companies, advertisers, government, or
others who might have conflicts of interest.
Reviewers must decline to review any manuscript
applications with which they may have a competition
of interest and should avoid reviewing any manu-
script if circumstances exist that could be viewed as
affecting their impartiality. For example, a reviewer
should not review a manuscript submitted by a close
personal friend, individuals from his or her institu-
tion, individuals with whom the reviewer has collab-
orated, or a scientist with whom the reviewer has had
long-standing scientific or personal differences.
When the reviewer is uncertain as to whether a con-
flict exists, he or she should inform the Editor of the
circumstances and the Editor will make the final
decision.
The peer review process. Fewer than half of the
manuscripts received by the Journal can be published.
The Editors and reviewers, by providing prompt and
authoritative review, aim to optimize the quality of
the published papers.
All submitted manuscripts are reviewed initially by
the Editors or Associate Editors. A submission may
be rejected outright if at least two of the Editors
conclude that it does not have sufficient merit to
warrant further review or deals with subject matter
outside the scope of the Journal.
Other manuscripts will be sent to two or three
members of the Editorial board or other expert con-
sultants for external peer review. The identities of
these reviewers are kept confidential. Reviewers are
asked to give the Editors a confidential opinion on
the importance, originality, and scientific merit of the
manuscript; rank its importance relative to what has
already been published in the medical literature; rank
its importance regarding inclusion on the cover and
use on the Web site for CME; and suggest changes
that will improve the paper.
A formal statistical review may be obtained to
ensure that the study population was clearly defined,
that the design of the study was suitable, that appro-
priate statistical methods were used, and that the
subsequent conclusions were supported by the data
and their analysis.
If two manuscripts are received on the same sub-
ject, unless both can be accommodated in the Jour-
nal, priority in the review process will be given to the
manuscript that was submitted first as determined by
the submission date in the Editorial Manager system.
The Editor will promptly contact the authors of the
second manuscript to inform them of the problem
and give them the option of submitting their manu-
script to another journal.
Administrative issues related to peer review.
Authors are expected to comply with the published
Information for Authors. The Journal’s requirements
for submission of a manuscript are in accordance with
the “Uniform Requirements for Manuscripts Sub-
mitted to Biomedical Journals: Writing and Editing
JOURNAL OF VASCULAR SURGERY/July 2010 31A
for Biomedical Publication” published in JAMA
1997;277:927-34 and available at http://www.
icmje.org/index.html. Failure to adhere to these
guidelines may negatively influence the opinions of
the Editors and reviewers, and thus the manuscript
may be returned to the author for appropriate revi-
sions in organization before it is sent out for peer
review.
The Editors will convey the final decision on the
disposition of the manuscript to the designated cor-
responding author along with the reasons for the
decision and the complete or summarized comments
from the reviewers.
If revisions are requested, the Editors expect the
authors to revise the manuscript appropriately and
promptly to meet publication deadlines. The authors
must clearly indicate the changes that have been
made and/or explain their difference of opinion with
the reviewers. More specific directions can be found
in the Journal’s Information for Authors.
The Editors will send the reviewers a notification
of their final decision on the disposition of a manu-
script and, when appropriate to the review process,
the comments of other reviewers.
TRANSFER OF COPYRIGHT OWNERSHIP
TO THE JOURNAL
Before a manuscript can be published, the authors
must provide a signed agreement transferring, assign-
ing, or conveying all copyright ownership of their
manuscript to the Society for Vascular Surgery®.
Hence, manuscripts accepted for publication become
the permanent property of the Society and may not
be published elsewhere by the authors without writ-
ten permission from the Journal. Once the manu-
script has been accepted, the publisher’s office will
send a Copyright Transfer form to the corresponding
author. This form must be completed, signed, and
sent back to the publisher’s office without delay. Cop-
ies of the copyright document will be kept indefi-
nitely.
Manuscripts written by employees of the federal
government during the course of their official duties
may not be copyrightable. If the author falls under
this designation, it should be appropriately noted in
the Copyright Transfer form.
Subsequent to acceptance for publication, if the
authors withdraw their manuscript, the Journal may
make appropriate charges to cover the production
costs incurred.
An individual may make a single photocopy of a
published article for his or her personal use, but
multiple copies cannot be made without the written
permission of the Journal or from the Copyright
Clearance Center. Permissions can be sought by con-
tacting Elsevier directly at (215) 239-3804 or by
e-mail at healthpermissions@elsevier.com.
ORIGINALITY OF MANUSCRIPT
The authors must certify that their article is origi-
nal, has been written by the stated authors, has not
been published previously, and is not under consid-
eration for publication by another journal. These,
and other warranties, are attested to when the Copy-
right Transfer form is signed.
Previous presentations and abstracts. If the
work has been presented previously at a meeting as an
oral presentation or poster or has been published in
an abstract, a detailed report will be considered for
publication. However, the authors are expected to
submit the details of the previous presentations and
provide the abstracts. In general, manuscripts will not
be considered if the work had been published previ-
ously in full-length conference proceedings or as a
book chapter.
Major update of a previous study. If the submit-
ted manuscript is a major update on the results of a
previously published study, the authors must submit
copies of the previous papers so that the Editors can
determine whether the new paper provides significant
new information or statistical power to warrant pub-
lication. In general, such updates should increase the
number of patients by at least 50% or the reported
mean follow-up by at least 2 years.
Media releases. The Editors recognize that news
organizations have the right to disseminate informa-
tion that may have been obtained from a presentation
at a scientific meeting or through direct discussions
with the author. It is the author’s responsibility to
inform the Editors that the work has been reported
previously by a journalist and explain the circum-
stances. In doing so, the authors should supply the
Editors with the original media report.
If the results of the study may potentially have a
major impact on patient management, the authors
can request the Editor’s consideration of prompt
review and publication.
Once submitted to the Journal, discussion of the
contents of a manuscript with the media must be
delayed until the review process is complete and the
manuscript is posted at the Journal’s Web site pend-
ing publication unless the Editors provide prior ap-
proval. If the authors provide additional information
to the media during the peer-review process, the
article may be rejected or withdrawn from publica-
tion.
In some instances, the Editors may ask the authors
to prepare a brief press release summarizing the
manuscript. However, as with all papers, further dis-
cussion of the results with themedia must be deferred
until the acceptance and postings of the manuscript.
Multiple publication. A joint publication or sec-
ondary publication of a full-length paper in another
journal may be considered if the manuscript contains
important information that deserves to be dissemi-
nated to a significantly different readership than that
of the Journal. The Journal Editors may grant per-
mission for secondary publication in another journal
if the original report in the Journal is appropriately
acknowledged and the secondary publication follows
the initial publication in the Journal. Abstracts or
full-length summaries of papers presented at meet-
ings may be published simultaneously in another
journal with permission of the Editors of both jour-
nals providing an appropriate acknowledgment is
made in each journal.
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AUTHORSHIP
It is not appropriate to include an individual as an
author unless he or she has made a significant contri-
bution to the conception or completion of the manu-
script and is willing to share the responsibility for the
content of the paper. Specifically, each of the authors
should have made a direct and substantial contribu-
tion to the following areas: (1) conceiving and de-
signing the study and/or analyzing and interpreting
the data; (2) writing the manuscript or providing
critical revisions that are important for the intellectual
content; and (3) approving the final version of the
manuscript. For more information on the require-
ments for authorship, see the “Uniform Require-
ments for Manuscripts Submitted to Biomedical
Journals: Writing and Editing for Biomedical Publi-
cation” (http://www.icmje.org/index.html), sec-
tion II.A on Authorship and Contributorship.
Each of the authors will be expected to read the
Author Role, Originality and Competition of Interest
form submitted by the corresponding author. By
signing the Copyright Transfer form once the paper is
accepted, the corresponding author attests to the
accuracy of the Author Role, Originality, and Com-
petition of Interest form.
Generally, the maximum number of expected au-
thors for a clinical or basic research manuscript is
eight, and for a case report or technical note, six. The
Editors request that additional authors be carefully
examined with respect to the authorship criteria listed
above, and suggest that some might better be ac-
knowledged than listed as authors. Further, the Edi-
tors request that authors beyond this expected num-
ber be specifically justified in the details section of the
electronic submission. In special circumstances (eg,
multi-center trials), the editors will consider as many
as ten authors for clinical or basic research papers, and
six for case reports and technical notes, but this is the
absolute maximum. As an alternative, a smaller num-
ber of key authors can submit the work on behalf of a
larger research group, which can then be listed and
acknowledged in an appendix. If an author has col-
laborated in a project but does not meet all the
requirements for authorship, he or she should be
recognized in the acknowledgment section of the
manuscript.
Beginning in January 2005, the Journal will pub-
lish an Author Contribution Statement at the end of
each clinical and basic research manuscript. The in-
formation for this statement should first be submitted
as part of the Author Role form upon submission, and
attested to by a completed Author Contribution
Statement form at the time of acceptance. For further
information, please see “Criteria for Authorship” J
Vasc Surg 2005;42:599.
The order of the authors’ names is at the discretion
of the coauthors, who may wish to add a footnote
explaining the order of authorship and/or their con-
tributions.
ORIGINAL DATA
The authors must be prepared to provide their
original data for review by the Editors and/or review-
ers if requested. The Author Role, Sponsor Involve-
ment, and Competition of Interest form requires the
authors to produce the data on which the manuscript
is based for examination by the Editors or their
assignees, should they request it.
The authors are responsible for keeping their orig-
inal data and experimental notes on file for a reason-
able period of time in case a question should arise
about the manuscript after it has been published.
The authors should consider including a footnote
in the manuscript indicating their willingness to make
the original data available to other investigators
through electronic media to permit alternative anal-
ysis and/or inclusion in meta-analysis.
CLINICAL TRIAL REGISTRATION
In 2004, the International Committee of Medical
Journal Editors (ICMJE) recommended that clinical
trials be registered in a public database as a prerequi-
site for subsequent publication (De Angelis C, Dra-
zen JM, Frizelle FA, et al. Clinical trial registration: a
statement from the International Committee of
Medical Journal Editors. N Engl J Med 2004; 351:
1250–1). Effective July 1, 2007 the Journal of Vas-
cular Surgery® will adopt the policies recommended
by the ICMJE and require the pre-registration of all
prospective clinical trials that have a control group
(Cronenwett J, Seeger J. Requirement for Registra-
tion of Clinical Trials. J Vasc Surg 2007;45:1). In
addition, the Journal will also require the pre-regis-
tration of any commercially sponsored clinical trial,
including Phase I and II trials. We do not anticipate
registration of retrospective reviews or summaries of
standard clinical treatment. Clinical trials that meet
the above requirement and commence after July 1,
2007 must be registered prior to enrollment of the
first patient. Relevant trials that began before this
date must be registered prior to editorial review.
Registration must be indicated by providing the
unique study number assigned at www.clinicaltrials.
gov, the principle site of registration sponsored by the
National Library ofMedicine (NLM).Detailed direc-
tions and a tutorial for registering a trial are available
at http://prsinfo.clinicaltrials.gov. Authors of un-
registered trials or those with inadequate information
in the registry will be given an opportunity to con-
vince the Editors that their rationale for omitting this
was critical, but it is the Journal’s expectation that
clinical trials involving prospective comparison of
treatment or any that are commercially sponsored will
all be registered after July 1, 2007.
AUTHORS’ DISCLOSURE OF
COMPETITIVE INTERESTS
The authors’ university, institutional, and/or
corporate affiliations will be acknowledged on the
title page along with sources of funding. In addi-
tion, the Journal expects the authors to disclose any
commercial associations that might represent a
competition of interest in respect to the manu-
script. If a company’s product is mentioned in a
manuscript or other articles, including letters to
the Editor and Editorials, all authors are expected
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to declare whether they have a consulting or em-
ployment arrangement or a royalty or stock agree-
ment with the company. The authors must indicate
any competition of interests or the lack thereof in
the Author Role, Originality, and Competition of
Interest form that is required before a manuscript
can be sent out for review. During the review
process, this relationship will be held in confidence.
A competition of interest statement is published
with each paper (Johnston KW, Rutherford RB. Dis-
closure of competition of interest J Vasc Surg 1999;
30:200-2). If a paper is accepted for publication, the
authors will be asked to clarify and update their
competitive interest statements.
Failure to disclose a competition of interest will be
dealt with according to the following, which has been
published in the Journal. (Johnston KW, Rutherford
RB. Failure to disclose competitive interest. J Vasc
Surg 2000;31:1306). “If it is brought to the Editors’
attention that an author may have failed to make an
appropriate disclosure, the Editors will give the au-
thor the opportunity to explain. If a satisfactory ex-
planation is not forthcoming, the Editors will bring
the issue to the attention of the author’s institution
for clarification. If the oversight can be explained as
an honest mistake, a simple notation of the error will
be published. If there was either self-deception or a
deliberate attempt to conceal a significant financial
competitive interest, the Editors will conclude that
this may represent an attempt to deceive and may be
a violation of public and professional trust. The Edi-
tors may publish a notation that the paper may be
unreliable because the author did not meet the stan-
dards of honest disclosure of competitive interests
required by the Journal.”
ETHICAL AND ANIMAL
EXPERIMENTATION APPROVAL
Human subjects. Manuscripts that involve re-
search conducted on human subjects must follow the
principles outlined in the Declaration of Helsinki
(http://www.wma.net/e/policy/pdf/17c.pdf) and
include a statement in the Methods section that the
experimental protocol and informed consent were
approved by the Institutional Review Board and that
all subjects gave informed consent. The Editors re-
serve the right to reject a manuscript if the authors fail
to make these statements in the manuscript or if, at
the request of the Editor, they do not provide appro-
priate documentation that their studies had appropri-
ate approval by their Institutional Review Board and
that informed consent was obtained from each pa-
tient.
Animal experiments.Manuscripts that report an-
imal experiments must include a statement in the
Methods section that the study was approved by the
Institutional Review Board and that the animal care
complied with the Guide for the Care and Use of
Laboratory Animals, Institute of Laboratory Animal
Resources, Commission on Life Sciences, National
Research Council. Washington: National Academy
Press, 1996. (http://stills.nap.edu/readingroom/
books/labrats/)
CONSENT TO REPRODUCE PREVIOUSLY
PUBLISHED DATA
It is the authors’ responsibility to obtain written
consent from the copyright owner and the original
author to reproduce direct quotations, tables, or
illustrations that have appeared in copyrighted mate-
rial and to provide complete information regarding
their source. Similarly, permission must be obtained
for tables and figures that have been modified from
other publications.
PATIENT CONSENT FOR REPRODUCING
PHOTOGRAPHS AND CASE HISTORIES
Photographs of identifiable persons must be ac-
companied by signed releases from patients or from
both living parents or guardians of minors. Similarly,
consent must be obtained if a person can be identified
from the case description.
COPYEDITING
A manuscript that is accepted for publication is
subject to copyediting so that it will conform to the
Journal’s standards and style. The revised manuscript
will be returned to the authors for approval. By
approving the changes, the authors accept the re-
sponsibility for the changes made in their manuscript
by the copy editor.
SEQUENCE OF PUBLICATION
In general, manuscripts are published in the order
they are received, providing that the Journal receives
revisions in a timely fashion. Under unusual circum-
stances, a paper may be assigned priority for early
publication if, in the view of the Editors, it contains
important new information that should be brought
to the attention of the readers immediately.
PUBLISHED DISCUSSIONS
The discussions of papers presented at The Society
for Vascular Surgery and at some of the meetings of
the affiliated societies will be published with the
manuscripts if they are submitted in a timely fashion;
however, these discussions are subject to Editorial
review and only those that enhance the text or present
alternative views will be published.
SCIENTIFIC MISCONDUCT
Misconduct in science was defined by the Na-
tional Academy of Sciences, National Academy of
Engineering, and the Institute of Medicine in 1992
as fabrication (ie, making up) of data or results,
falsification (ie, changing) of data or results, or
plagiarism (ie, unauthorized use of the words, data,
or ideas of another person without giving appro-
priate credit) in proposing, performing, or report-
ing research. Misconduct in science does not in-
clude errors in the scientific method or in
experimental design or data interpretation. In deal-
ing with alleged scientific misconduct, the appro-
priate steps in the process include informing the
authors of the allegations, requesting clarification,
determining whether the misconduct did or did
not occur, and, to the extent possible, establishing
the intent, ascertaining whether there were miti-
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gating factors, and making recommendations for
appropriate action. If a charge of scientific miscon-
duct appears to be justified, it is the Editors’ re-
sponsibility to refer the matter to the appropriate
individual at the authors’ university or institution
where the work was done. The university or insti-
tution has the responsibility to investigate alleged
scientific misconduct.
If the charge of scientific misconduct is substanti-
ated, the Journal will print a retraction and may
impose sanctions that could include a restriction on
future publication in the Journal. The decision to
issue a retraction generally must be made by the
authors and/or the appropriate authorities at the
university or institution who have access to the full
details of the investigation. A published retraction
will include the title of the original article, the same
first author as in the original paper, the reasons why
the article is being retracted, the circumstances of the
case, and a bibliographic reference to the original
paper. The retraction will be listed under a separate
heading in the Table of Contents.
CORRECTION OF ERRORS
As part of the scientific process, errors may be
discovered after publication that require clarification,
correction, or retraction of the paper. The Editor will
handle errors on an individual basis after discussion
with the authors.
BIBLIOGRAPHY
Altman LK. Bringing the news to the public: the
role of the media. Ann N Y Acad Sci 1993;703:
200-9.
Berk RN. Is plagiarism ever insignificant? AJR
Am J Roentgenol 1991;157:643-4. Comment in
AJR Am J Roentgenol 1993;160:1145-6.
Buzzelli DE. The definition of misconduct in sci-
ence: a view from NSF. Science 1993;259:584-5,
647-8.
Editorial Policy Committee, Council of Biological
Editors. Ethics and policy in scientific publication.
Bethesda, Md.: Council of Biological Editors, 1990.
Gordon IJ. Plagiarism [letter]. Nature 1989;341:
682.
International Committee of Medical Journal Edi-
tors. Retraction of research findings. BMJ 1988;296:
400.
International Committee of Medical Journal Edi-
tors. Uniform requirements for manuscripts submitted
to biomedical journals. JAMA 1997;277:2927-34.
Instruction for international authors. JAMA1995;
274:91-8.
Kassirer JP. Dissemination of medical informa-
tion: a journal’s role. Annals of the Academy of
Science 1993;272:173-9.
Lock S. Repetitive publication: a waste that must
stop. BMJ 1984;288:661-2.
McCloskey I. An NHMRC code for the conduct
of science. Med J Aust 1990;153:574-5.
Medical Research Council of Canada. Guidelines
for grant review. 1995.
Palca J. Plagiarism dispute. Clinical researchers at
odds [news]. Nature 1989;338:192.
Responsible science: ensuring the integrity of the
research process. Vol. 1. Washington: National Acad-
emy Press, 1992.
Schachman HK. What is misconduct in science?
Science 1993;261:148-9.
JOURNAL OF VASCULAR SURGERY/July 2010 35A
